Frontal lobe dementia with novel tauopathy: Sporadic multiple system tauopathy with dementia

Journal of Neuropathology and Experimental Neurology

Volumn 60, Issue 4, 2001, Pages 328-341

  Bigio, Eileen H ^a   Lipton, Anne M ^a   Yen, Shu Hui ^b   Hutton, Mike L ^b   Baker, Matt ^b   Nacharaju, Parimala ^b   White III, Charles L ^a   Davies, Peter ^c   Lin, Wenlang ^b   Dickson, Dennis W ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Corticobasal ganglionic degeneration; Dementia; Frontal lobe dementia; Frontotemporal degeneration; FTDP 17; Progressive supranuclear palsy; Tauopathy

Indexed keywords

SARKOSYL INSOLUBLE TAU PROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; CASE REPORT; CORTICOBASAL DEGENERATION; DEMENTIA; DENTATE NUCLEUS; DEPHOSPHORYLATION; FEMALE; FRONTAL LOBE DEMENTIA; FRONTOTEMPORAL DEMENTIA; GLIOSIS; GLOBUS PALLIDUS; HISTOPATHOLOGY; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SPORADIC MULTIPLE SYSTEM TAUOPATHY; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; TAUOPATHY; TISSUE DISTRIBUTION;

EID: 0035063346     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/60.4.328     Document Type: Article

References (73)

1. Filamentous nerve cell inclusions in neurodegenerative diseases: Tauopathies and alpha-synucleinopathies
2. τ, ubiquitin, and αB-crystallin immunohistochemistry define the principal causes of degenerative frontotemporal dementia
3. The new neuropathology of degenerative frontotemporal dementias
4. Review: Tau protein pathology in Alzheimer's disease and related disorders
5. Tau protein pathology in neurodegenerative diseases
6. Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration
7. Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease
8. Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease
9. Neurodegenerative disorders with extensive tau pathology: A comparative study and review
10. Association of an extended haplotype in the tau gene with progressive supranuclear palsy
11. Over-expression of four-repeat tau mRNA isoforms in progressive supra-nuclear palsy but not in Alzheimer's disease
12. Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: Tau pathologies with exclusively "exon 10" isoforms
13. Genetic evidence for the involvement of tau in progressive supranuclear palsy
14. Neurofibrillary tangle parkinsonian disorders - Tau pathology and tau genetics
15. Neuropathologic differentiation of progressive supra-nuclear palsy and corticobasal degeneration
16. Familial progressive supranuclear palsy. Description of a pedigree and review of the literature
17. The gau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases
18. First familial cases of corticobasal degeneration
19. Senile dementia with tangles (tangle predominant form of senile dementia)
20. Biochemical and molecular characterization of neurofibrillary degeneration in frontotemporal dementias
21. Tau mutations cause frontotemporal dementias
22. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
23. Chromosome 17-linked dementias
24. Frontotemporal dementia and parkinsonism linked to chromosome 17: A new group of tauopathies
25. Frequency of tau mutations in three series of non-Alzheimer's degenerative dementia
26. Tau is a candidate gene for chromosome 17 frontotemporal dementia
27. Mutation in the tau exon 10 splice site region in familial frontotemporal dementia
28. Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference. Conference Participants
29. Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex
30. Tau mutations in frontotemporal dementia
31. Phenotypic variation in hereditary frontotemporal dementia with tau mutations
32. Tau pathology in a family with dementia and a P301L mutation in tau
33. A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L)
34. From genotype to phenotype: A clinical, pathological, and biochemical investigation of frontotemporal dementia and parkinsonism (FTDP-17) caused by the P301L tau mutation
35. Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau
36. A distinct familial presenile dementia with a novel missense mutation in the tau gene
37. A mutation at codon 279 (N279K) in exon 10 of the tau gene causes a tauopathy with dementia and supranuclear palsy
38. The neuropathology of a chromosome 17-linked autosomal dominant Parkinsonism and dementia ("pallido-ponto-nigral degeneration")
39. Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17
40. Neuropathological features of frontotemporal dementia and parkinsonism linked to chromosome 17q21-22 (FTDP-17): Duke family 1684
41. Comparison of the neurofibrillary pathology in Alzheimer's disease and familial presenile dementia with tangles
42. Familial presenile dementia with psychosis associated with cortical neurofibrillary tangles and degeneration of the amygdala
43. Tau gene mutation in familial progressive subcortical gliosis
44. Localization of frontotemporal dementia with parkinsonism in an Australian kindred to chromosome 17q21-22
45. High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands
46. Hereditary frontotemporal dementia is linked to chromosome 17q21-22: A genetic and clinicopathological study of three Dutch families
47. Tau pathology in two Dutch families with mutations in the microtubule-binding region of tau
48. Familial multiple system tauopathy with presenile dementia: A disease with abundant neuronal and glial tau filaments
49. Familial multiple-system tauopathy with presenile dementia is localized to chromosome 17
50. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
51. A novel mutation at position + 12 in the intron following exon 10 of the tau gene in familial frontotemporal dementia (FTD-Kumamoto)
52. "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician
53. The association between quantitative measures of dementia and of senile change in the cerebral gray matter of elderly subjects
54. A new clinical scale for the staging of dementia
55. Global deterioration scale (GDS)
56. Cerebral blood flow in dementia
57. Neuropathological stageing of Alzheimer-related changes
58. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
59. FTDP-17 mutations N279K and S305N in tau produce increase splicing of exon 10
60. Fibrillogenesis of tau: Insights from tau missense mutations in FTDP-17
61. Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements
62. 5′ Splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10
63. Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly
64. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17
65. Structure of tau exon 10 splicing regulatory, element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17
66. Accelerated filament formation from tau protein with specific FTDP-17 missense mutations
67. The tau mutation (val337met) disrupts cytoskeletal networks of microtubules
68. Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation
69. Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments
70. Abnormal microtubule packing in processes of SF9 cells expressing the FTDP-17 V337M tau mutation
71. Missense tau mutations identified in FTDP-17 have a small effect on tau-microtubule interactions
72. Autopsy-proven progressive supranuclear palsy in two siblings
73. Familial dementia with swollen achromatic neurons and corticobasal inclusion bodies: A clinical and pathological study